Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients

NCT02706678 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplant Recipients

Interventions

DRUG: Tacrolimus sustained-release capsule

Sponsor

Astellas Pharma China, Inc.